This text is a result of machine translation.
Guangtian group: relevant overdue bank debts have a certain impact on the company's current or future profits
China's advanced multi-purpose helicopter ac352 completes functional and reliability test flight
Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum
A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.
May 18, 2026 02:22 PM
The total amount of "20 Jinke 03" bonds of Jinke Co., Ltd. through the 12-month extension scheme is 1.25 billion yuan
Cbcirc: rural small and medium-sized banks shall not absorb large deposits from other places or issue loans from other places
Research
Embodied AI2026 Full-Scope Report on Global Expansion of China's Embodied Intelligence Enterprises
US regulators say they are actively seeking to reach a cooperation agreement with China to end years of cross-border audit and supervision dilemma
Unpacking China | Key Chinese Firms to Watch This Week (26/07/2026-01/08/2026)
Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.
Updated 11 hours ago
TikTok Tests Paid Microdrama App LimeShorts in US, Taking On ReelShort and DramaBox
TikTok has been testing a paid standalone microdrama app in the United States called LimeShorts since March, expanding its push into a category dominated by dedicated platforms such as ReelShort and DramaBox.
Yesterday 03:09 PM
Housing stocks in Hong Kong stocks strengthened, and rongchuang China rose more than 5%
Mabwell Signs GCC Licensing Deal with Saudi Arabia’s SVAX for Aflibercept Biosimilar
Mabwell (Shanghai) Bioscience Co., Ltd.(迈威(上海)生物科技股份有限公司)has entered into a licensing agreement with Saudi Arabian biopharmaceutical company SVAX Inc. covering its aflibercept biosimilar, 9MW0813, in the Gulf Cooperation Council market.
Yesterday 03:00 PM
Tesla Austin super factory installs Longji photovoltaic products
A Small Aircraft, a Bigger Bet: How China's Worthy Aero Plans to Scale Up
Yesterday 02:44 PM
EqualOcean Releases 2026 Chinese GoGlobal Physical Retail Brands Top 10 at GGF2026
Jun 17, 2026 02:50 PM